EW vs THRY · P/E 47, rev $1.39B vs P/E 11, rev $824.2M
Edwards Lifesciences Corp (EW) versus Thryv Holdings Inc (THRY) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Thryv Holdings Inc (THRY) is a software - application company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported THRY revenue for 2024-12-31 was $824.2M. Net income was -$74.2M. Revenue was down 10.1% from 2023-12-31 to 2024-12-31. THRY currently screens at market cap $156.6M and trailing P/E 10.7.
EW currently screens at market cap $49.91B and trailing P/E 46.9. THRY currently screens at market cap $156.6M and trailing P/E 10.7.
Not investment advice. Open the EW and THRY stock pages for the full models.
Not investment advice.